Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,564 | 41 | 38.2% |
| Consulting Fee | $2,209 | 7 | 32.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,934 | 3 | 28.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neuronetics, Inc. | $5,615 | 34 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $540.07 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $116.35 | 1 | $0 (2024) |
| Medtronic USA, Inc. | $115.30 | 1 | $0 (2017) |
| Novo Nordisk Inc | $105.53 | 1 | $0 (2017) |
| LivaNova USA, Inc. | $94.04 | 1 | $0 (2024) |
| ABBVIE INC. | $51.62 | 3 | $0 (2024) |
| Axsome Therapeutics, Inc. | $29.80 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.62 | 1 | $0 (2023) |
| Alkermes, Inc. | $18.59 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $423.15 | 7 | Janssen Pharmaceuticals, Inc ($163.06) |
| 2023 | $249.45 | 6 | Janssen Pharmaceuticals, Inc ($178.52) |
| 2022 | $104.05 | 1 | Janssen Pharmaceuticals, Inc ($104.05) |
| 2020 | $1,531 | 6 | Neuronetics, Inc. ($1,531) |
| 2019 | $351.15 | 7 | Neuronetics, Inc. ($256.71) |
| 2018 | $3,069 | 15 | Neuronetics, Inc. ($3,069) |
| 2017 | $980.02 | 9 | Neuronetics, Inc. ($759.19) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $116.35 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/21/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $94.04 | General |
| Category: Neurology | ||||||
| 06/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Neuroscience | ||||||
| 05/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: Neuroscience | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $146.90 | General |
| Category: Neuroscience | ||||||
| 02/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $98.25 | General |
| Category: Neuroscience | ||||||
| 10/26/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: CNS | ||||||
| 09/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $80.27 | General |
| Category: Neuroscience | ||||||
| 10/11/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $104.05 | General |
| Category: Neuroscience | ||||||
| 10/01/2020 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Consulting Fee | Cash or cash equivalent | $137.50 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 09/08/2020 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Consulting Fee | Cash or cash equivalent | $137.50 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 08/11/2020 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Consulting Fee | Cash or cash equivalent | $275.00 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 07/21/2020 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Consulting Fee | Cash or cash equivalent | $137.50 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 03/11/2020 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Consulting Fee | In-kind items and services | $825.00 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 03/10/2020 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 09/11/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $94.44 | General |
| Category: Neuroscience | ||||||
| 04/26/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 03/28/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 03/01/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 02/21/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $99.97 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 129 | 921 | $554,598 | $115,424 |
| 2022 | 4 | 118 | 700 | $213,307 | $86,871 |
| 2021 | 4 | 126 | 773 | $225,633 | $96,222 |
| 2020 | 5 | 161 | 782 | $189,754 | $81,662 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 19 | 628 | $475,000 | $87,516 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 217 | $42,858 | $18,478 | 43.1% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2023 | 15 | 16 | $20,800 | $4,528 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 41 | $8,212 | $2,676 | 32.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 17 | 19 | $7,728 | $2,225 | 28.8% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 19 | 415 | $166,000 | $58,658 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 253 | $33,644 | $21,670 | 64.4% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2022 | 16 | 17 | $10,200 | $4,908 | 48.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 15 | 15 | $3,462 | $1,635 | 47.2% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 16 | 440 | $174,017 | $62,791 | 36.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 305 | $40,285 | $27,498 | 68.3% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), initial delivery and management | Office | 2021 | 14 | 14 | $8,400 | $4,221 | 50.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 14 | 14 | $2,932 | $1,712 | 58.4% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 16 | 345 | $135,715 | $46,982 | 34.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 305 | $34,514 | $22,242 | 64.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 81 | $12,270 | $8,161 | 66.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 25 | 33 | $4,004 | $2,568 | 64.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 18 | 18 | $3,250 | $1,709 | 52.6% |
About William West, MD, PLLC
William West, MD, PLLC is a Psychiatry healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598862591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William West, MD, PLLC has received a total of $6,707 in payments from pharmaceutical and medical device companies, with $423.15 received in 2024. These payments were reported across 51 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,564).
As a Medicare-enrolled provider, West has provided services to 534 Medicare beneficiaries, totaling 3,176 services with total Medicare billing of $380,179. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Nashville, TN
- Active Since 09/20/2006
- Last Updated 11/20/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598862591
Products in Payments
- NEUROSTAR TMS THERAPY (Device) $4,856
- NeuroStar TMS Therapy (Device) $759.19
- SPRAVATO (Drug) $540.07
- COBENFY (Drug) $116.35
- Solitaire (Device) $115.30
- Victoza (Drug) $105.53
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $94.04
- VRAYLAR (Drug) $51.62
- Auvelity (Drug) $29.80
- TRINTELLIX (Drug) $20.62
- ARISTADA (Drug) $18.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Nashville
Rakesh Amin, M.d, M.D
Psychiatry — Payments: $2.2M
Dr. Robert Jamieson, M.d, M.D
Psychiatry — Payments: $273,384
Jon Draud, M.d, M.D
Psychiatry — Payments: $202,474
Dr. Michelle Cochran, M.d, M.D
Psychiatry — Payments: $62,462
Dr. Craig Clark, M.d, M.D
Psychiatry — Payments: $52,548
Dr. Robert Hunt, M.d, M.D
Psychiatry — Payments: $42,897